Table 1. Baseline data in the 2 groups.
| Variables | CR group (n=195) | Control group (n=390) | P value |
|---|---|---|---|
| Female, n (%) | 107 (54.9) | 116 (29.7) | <0.001 |
| Age | 71.90±8.36 | 63.15±11.80 | <0.001 |
| Hypertension, n (%) | 129 (66.2) | 233 (59.7) | 0.132 |
| Diabetes mellitus, n (%) | 55 (28.2) | 116 (29.7) | 0.700 |
| Smoking, n (%) | 78 (40) | 133 (34.1) | 0.161 |
| Previous MI, n (%) | 10 (5.1) | 30 (7.7) | 0.247 |
| Previous PCI, n (%) | 21 (10.8) | 43 (11.0) | 0.925 |
| Previous CABG*, n (%) | 0 | 6 (1.5) | 0.186 |
| Previous stroke, n (%) | 49 (25.1) | 73 (18.7) | 0.072 |
| Previous bleeding disorder*, n (%) | 4 (2.1) | 5 (1.3) | 0.490 |
| Previous thrombotic diseases*, n (%) | 2 (1.0) | 8 (2.1) | 0.508 |
*, Fisher’s exact test was used. CR, cardiac rupture; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft.